GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Turk Ilac ve Serum Sanayi (IST:TRILC) » Definitions » EV-to-Revenue

Turk Ilac ve Serumnayi (IST:TRILC) EV-to-Revenue : 4.26 (As of May. 27, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Turk Ilac ve Serumnayi EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Turk Ilac ve Serumnayi's enterprise value is ₺5,139 Mil. Turk Ilac ve Serumnayi's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was ₺1,207 Mil. Therefore, Turk Ilac ve Serumnayi's EV-to-Revenue for today is 4.26.

The historical rank and industry rank for Turk Ilac ve Serumnayi's EV-to-Revenue or its related term are showing as below:

IST:TRILC' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.52   Med: 2.58   Max: 26.03
Current: 4.26

During the past 6 years, the highest EV-to-Revenue of Turk Ilac ve Serumnayi was 26.03. The lowest was 1.52. And the median was 2.58.

IST:TRILC's EV-to-Revenue is ranked worse than
71.95% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 2.29 vs IST:TRILC: 4.26

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Turk Ilac ve Serumnayi's stock price is ₺29.82. Turk Ilac ve Serumnayi's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was ₺6.89. Therefore, Turk Ilac ve Serumnayi's PS Ratio for today is 4.33.


Turk Ilac ve Serumnayi EV-to-Revenue Historical Data

The historical data trend for Turk Ilac ve Serumnayi's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turk Ilac ve Serumnayi EV-to-Revenue Chart

Turk Ilac ve Serumnayi Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-Revenue
Get a 7-Day Free Trial - - - 3.04 2.95

Turk Ilac ve Serumnayi Quarterly Data
Dec17 Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.22 2.95 1.61 1.85 2.36

Competitive Comparison of Turk Ilac ve Serumnayi's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Turk Ilac ve Serumnayi's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Turk Ilac ve Serumnayi's EV-to-Revenue falls into.



Turk Ilac ve Serumnayi EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Turk Ilac ve Serumnayi's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=5138.925/1206.911
=4.26

Turk Ilac ve Serumnayi's current Enterprise Value is ₺5,139 Mil.
Turk Ilac ve Serumnayi's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺1,207 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turk Ilac ve Serumnayi  (IST:TRILC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Turk Ilac ve Serumnayi's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=29.82/6.894
=4.33

Turk Ilac ve Serumnayi's share price for today is ₺29.82.
Turk Ilac ve Serumnayi's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺6.89.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turk Ilac ve Serumnayi EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Turk Ilac ve Serumnayi's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Turk Ilac ve Serumnayi (IST:TRILC) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Bügduz Mah. Enver Pasa Cad., No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.

Turk Ilac ve Serumnayi (IST:TRILC) Headlines

No Headlines